The association among APOC3 SNPs, serum lipid profile, and pathological scoring was then investigated to uncover the lipidomics-based intervention of APOC3 polymorphisms on NAFLD. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.